home · filing · 0001193125-25-137478
8-K filed June 9, 2025, 7:59 PM ET
ticker MRVI
CIK 0001823239
leadership
confidence high
sentiment neutral
materiality 0.65
Maravai LifeSciences appoints Bernd Brust as CEO, succeeding William Martin
MARAVAI LIFESCIENCES HOLDINGS, INC.
Bernd Brust named CEO and board member effective June 8, 2025; William Martin resigned as CEO and from board.
Brust's base salary is $750,000 with a target annual cash bonus of 100% of base salary.
Equity awards: 1M stock options, 2M RSUs, 2.25M PSUs; options and RSUs vest over three years.
Martin's departure not due to any disagreement; he is eligible for severance per existing agreement.
Company will revisit FY2025 guidance in August Q2 earnings call after Brust's assessment.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Effective 2025-06-08
Filed June 9, 2025, 7:59 PM ET
Mr. Martin resigned from the Board
Effective 2025-06-08
Filed June 9, 2025, 7:59 PM ET
Mr. Brust was appointed as a member of the Board
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
William E. Martin, III resigned as Director at MARAVAI LIFESCIENCES HOLDINGS, INC..
Action resigned
Role Director
Exact text from the filing
Mr. Martin resigned from the Board
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Bernd Brust was appointed as Director at MARAVAI LIFESCIENCES HOLDINGS, INC..
Action appointed
Role Director
Exact text from the filing
Mr. Brust was appointed as a member of the Board
View on SEC.gov
Source: SEC EDGAR
accession 0001193125-25-137478
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.